In a significant move highlighting their expertise in healthcare investments, Shore Capital Partners (“Shore Capital Partners”) announced the completion of the sale of EyeSouth Partners (“EyeSouth”) to Olympus Partners (“Olympus”) in October 2022. EyeSouth, a leading ophthalmology services provider across the eastern United States, represents a successful investment and strategic build by Shore Capital Partners within the healthcare sector.
Shore Capital Partners established EyeSouth Partners in 2017 with a clear vision: to cultivate a premier ophthalmology platform concentrated in the South, dedicated to delivering exceptional support to its affiliated practices and clinicians. This ambition began with a key strategic partnership with Georgia Eye Partners, where Dr. Eugene Gabianelli, the founding physician, took on the crucial role of Chief Medical Officer at EyeSouth, contributing his deep clinical expertise to the growing organization.
Under the leadership of Chief Executive Officer Rex Adams, EyeSouth experienced phenomenal expansion, growing its network exponentially from an initial 5 locations to over 155 locations spanning across 11 states, including Georgia, Texas, and Florida. This impressive growth trajectory was fueled by a dual approach: strategic mergers and acquisitions (M&A) and robust organic growth initiatives. Crucially, EyeSouth, backed by Shore Capital Partners, prioritized providing its physician partners with comprehensive support. This included strategic guidance, streamlined administrative resources, operational expertise, and necessary capital investments, all underpinned by a steadfast commitment to clinical excellence and a patient-centric approach.
The extensive network of affiliations under EyeSouth, fostered during Shore Capital Partners’ ownership, includes prominent names such as Georgia Eye Partners, Florida Eye Microsurgical Institute, and Eye Center of Texas, among many others. This broad portfolio demonstrates the platform’s reach and the successful execution of Shore Capital Partners’ strategy to consolidate and strengthen a leading market presence in the ophthalmology space. The successful sale of EyeSouth Partners underscores Shore Capital Partners’ proficiency in identifying and nurturing high-growth potential businesses within the healthcare market, culminating in a successful exit and value creation for all stakeholders.
